Construction and Characterization of Human CD7-Specific Single-Chain Fv Immunotoxins

Journal of Immunology

Volumn 158, Issue 7, 1997, Pages 3259-3269

  Pauza, Mary E ^a,b   Doumbia, Sekou O ^a   Pennell, Christopher A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCKING ANTIBODY; CD7 ANTIGEN; IMMUNOGLOBULIN FRAGMENT; IMMUNOGLOBULIN FV; IMMUNOTOXIN; MONOCLONAL ANTIBODY;

ANTIBODY SPECIFICITY; ARTICLE; CELL CULTURE; CHEMISTRY; GENETICS; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGY; METABOLISM; MOLECULAR CLONING; T CELL LEUKEMIA;

ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, CD7; CLONING, MOLECULAR; HUMANS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOTOXINS; LEUKEMIA, T-CELL, ACUTE; TUMOR CELLS, CULTURED;

EID: 0031110838     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Copelan, E. A., and E. A. McGuire. 1995. The biology and treatment of acute lymphoblastic leukemia in adults. Blood 85:1151.
2. Bachier, C. R., and C. F. LeMaistre. 1995. Immunotoxin therapy of cancer: rationale for development and future potential. Clin. Immunotherapeutics 3:450.
3. Caron, P. C., and D. A. Scheinberg. 1994. Immunotherapy for acute leukemias. Curr. Opin. Oncol. 6:14.
4. Frankel, A. E., E. P. Tagge, and M. C. Willingham. 1996. Clinical triais of targeted toxins. Cancer Biol. 6:307.
5. Ghetie, M. A., and E. S. Vitetta. 1994. Recent developments in immunotoxin therapy. Curr. Opin. Immunol. 6:707.
6. Gramatzki, M., R. Burger, G. Strobel, U. Trautmann, C. R. Bartram, G. Helm, S. Alsalameh, M. Jonker, E. Gebhart, and J. R. Kalden. 1995. Therapy with OKT3 monoclonal antibody in refractory T cell acute lymphoblastic leukemia induces interleukin-2 responsiveness. Leukemia 9:382.
7. Vallera, D. A. 1994. Immunotoxins: will their clinical promise be fulfilled? Blood 83:309.
8. Huston, J. S., J. McCartney, M. S. Tai, C. Mottola-Hartshorn, D. Jin, F. Warren, and H. Oppermann. 1993. Medical applications of single-chain antibodies. Int. Rev. Immunol. 10:195.
9. Pastan, I., V. Chaudhary, and D. J. FitzGerald. 1992. Recombinant toxins as novel therapeutic agents. Ann. Rev. Biochem. 61:331.
10. Huston, J. S., D. Levinson, M. Mudgett-Hunter, M. S. Tai, J. Novotny, M. N. Margolies, R. J. Ridge, R. E. Bruccoleri, E. Haber, R. Crea, and H. Opperman. 1988. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc. Natl. Acad. Sci. USA 85:5879.
11. Bird, R. E., K. D. Hardman, J. W. Jacobson, S. Johnson, B. M. Kaufman, S. M. Lee, T. Lee, S. H. Pope, G. S. Riordan, and M. Whitlow. 1988. Single-chain antigen-binding proteins. Science 242:423.
12. Yokota, T., D. E. Milenic, M. Whitlow, and J. Schlom. 1992. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res. 52:3402.
13. Chaudhary, V. K., C. Queen, R. P. Junghans, T. A. Waldmann, D. J. FitzGerald, and I. Pastan. 1989. A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin. Nature 339:394.
14. Cumber, A. J., E. S. Ward, G. Winter, G. D. Parnell, and E. J. Wawrzynczak. 1992. Comparative stabilities in vitro and in vivo of a recombinant mouse antibody FvCys fragment and a bisFvCys conjugate. J. Immunol. 149:120.
15. Vallera, D. A., L. J. Burns, A. E. Frankel, A. R. Schieneder, R. Gunther, K. Gajl-Peczalska, C. A. Pennell, and J. H. Kersey. 1996. Laboratory preparation of a deglycosylated ricin toxin A chain containing immuntoxin directed against a CD7 T lineage differentiation antigen for phase I human clinical studies involving T cell malignancies. J. Immunol. Methods 197:69.
16. Barcena, A., M. O. Muench, M. G. Roncarolo, and H. Spits. 1995. Tracing the expression of CD7 and other antigens during T- and myeloid-cell differentiation in the human fetal liver and thymus. Leuk. Lymphoma 17:1.
17. Ramsay, N, K., and J. H. Kersey. 1988. Bone marrow purging using monoclonal antibodies. J. Clin. Immunol. 8:81.
18. Uckun, F. M., D. E. Myers, J. A. Ledbetter, S. E. Swaim, and K. J. Gajl-Peczalska. 1988. Use of colony assays and anti-T cell immunotoxins to elucidate the immunobiologic features of leukemic progenitor cells in T-lineage acute lymphoblastic leukemia. J. Immunol. 140:2103.
19. Uckun, F. M., K. Gajl-Peczalska, D. E. Meyers, N. C. Ramsay, J. H. Kersey, M. Colvin, and D. A. Vallera. 1987. Marrow purging in autologous bone marrow transplantation for T-lineage acute lymphoblastic leukemia: efficacy of ex vivo treatment with immunotoxins and 4-hydroperoxycyclophosphamide against fresh leukemic marrow progenitor cells. Blood 69:361.
20. Tonevitsky, A. G., I. I. Agapov, E. B. Mechetner, G. V. Ershova, A. Y. Toptygin, A. T. Shamshiev, and U. Pfueller. 1993. Comparison of the cytotoxic activity of the immunotoxins with different internalization rates. Biochem. Mol. Biol. Int. 31:1059.
21. Carriere, D., J. M. Arcier, J. M. Derocq, C. Fontaine, and G. Richer. 1989. Antigenic modulation induced by four monoclonal antibodies adsorbed on gold particles (specificity anti-CD4, anti-CD5, anti-CD7, and anti-150-kDa antigen): relationship between modulation and cytotoxic activity of immunotoxins. Exp. Cell Res. 182:114.
22. + human acute T-cell leukaemia cell line. Br. J. Cancer 64:274.
23. Fishwild, D. M., S. Aberle, S. L. Bernhard, and A. H. Kung. 1992. Efficacy of an anti-CD7-ricin A chain immunoconjugate in a novel murine model of human T-cell leukemia. Cancer Res. 52:3056.
24. Jansen, B., D. A. Vallera, W. B. Jaszcz, D. Nguyen, and J. H. Kersey. 1992. Successful treatment of human acyte T-cell leukemia in SCID mice using the anti CD7-deglycosylated ricin A-chain immunotoxin DA7. Cancer Res. 52:1314.
25. Fishwild, D. M., M. O. Staskawicz, H. M. Wu, and S. F. Carroll. 1991. Cytotoxicity against human peripheral blood mononuclear cells and T cell lines mediated by anti-T cell immunotoxins in the absence of added potentiator. Clin. Exp. Immunol. 86:506.
26. Preijers, F. W. M. B., T. de Witte, J. M. C. Wessels, J. P. P. Meyerink, C. Haanen, and P. J. A. Capel. 1989. Cytotoxic potential of anti-CD7 immunotoxin (WT1-ricin A) to purge ex vivo malignant T ceils in bone marrow. Br. J. Haematol. 71:195.
27. Palker, T. J., R. M. Scearce, L. L. Hensley, W. Ho, and B. F. Haynes. 1984. Comparison of the CD7 (3A1) group of T cell workshop antibodies. In Leukocyte Typing II, Vol. 1. E. L. Rheinherz, ed. Springer-Verlag, New York, p. 303.
28. Amlot, P., and S. Cammisuli. 1990. CD7 monoclonal antibodies. In Therapeutic Monoclonal Antibodies. C. Borrebaeck and J. W. Larrick, eds. Stockton Press, New York, p. 287.
29. Foley, G. F., H. Lazarus, S. Farber, B. G. Uzman, B. A. Boone, and R. E. McCarthy. 1965. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 18:522.
30. Loh, E. Y., L. L. Lanier, C. W. Turck, D. R. Littman, M. M. Davis, Y. -H. Chien, and A. Weiss. 1987. Identification and sequence of a fourth human T cell antigen receptor chain. Nature 330:569.
31. Gazdar, A. F., D. N. Carney, P. A. Bunn, E. K. Russell, E. S. Jaffe, G. P. Schechter, and J. G. Guccion. 1980. Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas. Blood 55:409.
32. Fulton, R. J., D. C. Blakey, P. P. Knowles, J. W. Uhr, P. E. Thorpe, and E. S. Vitetta. 1986. Purification of ricin A1, A2, and B chains and characterization of their toxicity. J. Biol. Chem. 261:5314.
33. Barnstable, C. J., W. F. Bodmer, G. Brown, G. Galfre, C. Milstein, and A. F. Williams. 1978. Production of monoclonal antibodies to group A erythrocytes. HLA and other human cell surface antigens - new tools for genetic analysis. Cell 14:9.
34. + T lymphocytes. Proc. Natl. Acad. Sci. USA 88:6403.
35. Duzgunes, N., and P. L. Felgner. 1993. Intracellular delivery of nucleic acids and transcription factors by cationic liposomes. Methods Enzymol. 221:303.
36. Huston, J. S., M. Mudgett-Hunter, M. S. Tai, J. McCartney, F. Warren, and E. Haber. 1991. Protein engineering of single-chain Fv analogs and fusion proteins. Methods Enzymol. 203:46.
37. Power, B. E., N. Ivancic, V. R. Harley, R. G. Webster, A. A. Kortt, and R. A. Irving. 1992. High-level temperature-induced synthesis of an antibody VH-domain in Escherichia coli using the PelB secretion signal. Gene 113:95.
38. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of me head of bacteriophage T4. Nature 227:680.
39. Karlsson, R., H. Roos, L. Fagerstam, and B. Persson. 1994. Kinetic and concentration analysis using BIA technology. Methods 6:99.
40. Lindmo, T., E. Boven, F. Cuttitta, J. Fedorko, and P. A. Bunn. Jr. 1984. Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J. Immunol. Methods 72:77.
41. Press, O. W., J. Howell-Clark, S. Anderson, and I. Bernstein. 1994. Retention of B-cell-specific monoclonal antibodies by human lymphoma cells. Blood 83:1390.
42. Maier, L. A., F. J. Xu, S. Hester, C. M. Boyer, S. McKenzie, A. M. Bruskin, Y. Argon, and R. C. Bast, Jr. 1991. Requirements for the internalization of a murine monoclonal antibody directed against the HER-2/neu gene product c-erbB-2. Cancer Res. 51:5361.
43. Ghetie, M. A., J. Richardson, T. Tucker, D. Jones, J. W. Uhr, and E. S. Vitetta. 1991. Antitumor activity of Fab′ and IgG-anti-CD22 immunotoxins in disseminated human B lymphoma grown in mice with severe combined immunodeficiency disease: effect on tumor cells in extranodal sites. Cancer Res. 51:5876.
44. Brodeur, P. H., and R. Riblet. 1984. The immunoglobulin heavy chain variable region (Igh-V) locus in the mouse, I: one hundred Igh-V genes comprise seven families of homologous genes. Eur. J. Immunol. 14:922.
45. Sakano, H., R. Maki, Y. Kurosawa, W. Roeder, and S. Tonegawa. 1980. Two types of somatic recombination are necessary for the generation of complete immunoglobulin heavy-chain genes. Nature 286:676.
46. Chang, Y., C. J. Paige, and G. E. Wu. 1992. Enumeration and characterization of DJH structures in mouse fetal liver. EMBO J. 11:1891.
47. Sakano, H., K. Huppi, G. Heinrich, and S. Tonegawa. 1979. Sequences at the somatic recombination sites of immunoglobulin fight-chain genes. Nature 280: 288.
48. κ gene classification by nucleic acid sequence similarity. Immunogenetics 30:475.
49. Schaller, H., E. Beck, and M. Takanami. 1978. Sequence and regulatory signals of the filamentous phage genome. In The Single-Stranded DNA Phages. D. T. Denhardt, D. Dressier, and D. S. Ray, eds. Cold Spring Harbor Laboratory, New York, p. 139.
50. Sugimoto, D., H. Sugisaki, T. Okamoto, and M. Takanami. 1977. Studies on bacteriophage fd DNA IV: the sequence of messenger RNA for the major coat protein gene. J. Mol. Biol. 110:487.
51. Holvoet, P., Y. Laroche, H. R. Lijnen, B. Van Hoef, E. Brouwers, F. De Cock, Y. Gansemans, and D. Collen. 1992. Biochemical characterization of single-chain chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody and single-chain urokinase. Eur. J. Biochem. 210: 945.
52. Bejcek, B. E., D. Wang, E. Berven, C. A. Pennell, S. C. Peiper, S. Poppema, F. M. Uckun, and J. H. Kersey. 1995. Development and characterization of three recombinant single-chain antibody fragments (scFvs) directed against the CD19 antigen. Cancer Res. 55:2346.
53. Marks, J. D., H. R. Hoogenboom, T. P. Bonnert, J. McCafferty, and A. D. Griffiths. 1991. By-passing immunization: human antibodies from V-gene libraries displayed on phage. J. Mol. Biol. 222:581.
54. Friedman, P. N., S. J. McAndrew, S. L. Gawlak, D. Chace, P. A. Trail, and J. P. Brown. 1993. BR96 sFv-PE40, a potent single-chain immunotoxin that selectively kills carcinoma cells. Cancer Res. 53:334.
55. Ghetie, V., A. Engert, R. Schnell, and E. S. Vitetta. 1995. The in vivo anti-tumor activity of immunotoxins containing two versus one deglycosylated ricin A chains. Cancer Lett. 98:97.
56. Batra, J. K., D. J. FitzGerald, V. K. Chaudhary, and I. Pastan. 1991. Single-chain immuntoxins directed at the human transferrin receptor containing Pseudomonas exotoxin A or Diptheria toxin: anti-TFR(Fv)-PE40 and DT338-anti-TFR(Fv). Mol. Cell. Biol. 11:2200.
57. Buchner, J., I. Pastan, and U. Brinkmann. 1992. A method for increasing the yield of properly folded recombinant fusion proteins: single-chain immunotoxins from renaturation of bacterial inclusion bodies. Anal. Biochem. 205:263.
58. Pack, P., M. Kujau, V. Schroeckh, U. Knupfer, R. Wenderoth, and D. Riesenberg. 1993. Improved bivalent miniantibodies, with identical avidity as whole antibodies, produced by high cell density fermentation of Escherichia coli. Biotechnology 11:1271.
59. Cregg, J. M., T. S. Vedvick, and W. C. Raschke. 1993. Recent advances in the expression of foreign genes in Pichia pastoris. Biotechnology 11:905.
60. Eldin, P., M. E. Pauza, Y. Hieda, G. Lin, M. P. Murtaugh, P. R. Pentel, and C. A. Pennell. 1997. High-level secretion of two antibody single chain Fv fragments by Pichia pastoris. J. Immunol. Methods. In press.